Jemina Loganathan, Stergios K Doumouchtsis1,2,3,4. 1. Epsom and St Helier University Hospitals NHS Trust, Dorking Road, Epsom, KT18 7EG, UK. sdoumouc@sgul.ac.uk. 2. St George's University of London, London, UK. sdoumouc@sgul.ac.uk. 3. Laboratory of Experimental Surgery and Surgical Research N.S. Christeas, Athens University Medical School, Athens, Greece. sdoumouc@sgul.ac.uk. 4. American University of the Caribbean, School of Medicine, Pembroke Pines, FL, USA. sdoumouc@sgul.ac.uk.
Abstract
INTRODUCTION AND HYPOTHESIS: The coronavirus (COVID-19) pandemic has impacted health systems worldwide. There is a continuing need for clinicians to adapt practice to facilitate timely provision of medical care, whilst minimising horizontal transmission. Guidance and recommendations are increasingly available, and this rapid review aimed to provide a timely evidence synthesis on the current recommendations surrounding urogynaecological care. METHODS: We performed a literature review using PubMed/Medline, Embase and Cochrane and a manual search of national and international societies for management recommendations for urogynaecological patients during the COVID-19 pandemic. RESULTS: Nine guidance documents and 17 articles, including 10 reviews, were included. Virtual clinics are recommended for new and follow-up patients, to assess and initiate treatment, as well as triage patients who require face-to-face appointments. Outpatient investigations such as urodynamics and cystoscopy for benign indications can be deferred. Prolapse and continence surgery should be suspended, except in specific circumstances such as procidentia with upper tract complications and failed pessaries. There is no evidence to support a particular route of surgery, but recommendations are made to minimise COVID-19 transmission. CONCLUSIONS: Urogynaecological patients face particular challenges owing to inherent vulnerabilities of these populations. Behavioural and medical therapies should be recommended as first line options and initiated via virtual or remote clinics, which are integral to management during the COVID-19 pandemic. Expanding the availability and accessibility of technology will be increasingly required. The majority of outpatient and inpatient procedures can be deferred, but the longer-term effects of such practices are unclear.
INTRODUCTION AND HYPOTHESIS: The coronavirus (COVID-19) pandemic has impacted health systems worldwide. There is a continuing need for clinicians to adapt practice to facilitate timely provision of medical care, whilst minimising horizontal transmission. Guidance and recommendations are increasingly available, and this rapid review aimed to provide a timely evidence synthesis on the current recommendations surrounding urogynaecological care. METHODS: We performed a literature review using PubMed/Medline, Embase and Cochrane and a manual search of national and international societies for management recommendations for urogynaecological patients during the COVID-19 pandemic. RESULTS: Nine guidance documents and 17 articles, including 10 reviews, were included. Virtual clinics are recommended for new and follow-up patients, to assess and initiate treatment, as well as triage patients who require face-to-face appointments. Outpatient investigations such as urodynamics and cystoscopy for benign indications can be deferred. Prolapse and continence surgery should be suspended, except in specific circumstances such as procidentia with upper tract complications and failed pessaries. There is no evidence to support a particular route of surgery, but recommendations are made to minimise COVID-19 transmission. CONCLUSIONS: Urogynaecological patients face particular challenges owing to inherent vulnerabilities of these populations. Behavioural and medical therapies should be recommended as first line options and initiated via virtual or remote clinics, which are integral to management during the COVID-19 pandemic. Expanding the availability and accessibility of technology will be increasingly required. The majority of outpatient and inpatient procedures can be deferred, but the longer-term effects of such practices are unclear.
Authors: Christina Uwins; Geetu Prakash Bhandoria; T S Shylasree; Simon Butler-Manuel; Patricia Ellis; Jayanta Chatterjee; Anil Tailor; Alexandra Stewart; Agnieszka Michael Journal: Int J Gynecol Cancer Date: 2020-06-23 Impact factor: 3.437
Authors: Giacomo Novara; Enrico Checcucci; Alessandro Crestani; Alberto Abrate; Francesco Esperto; Nicola Pavan; Cosimo De Nunzio; Antonio Galfano; Gianluca Giannarini; Andrea Gregori; Giovanni Liguori; Riccardo Bartoletti; Francesco Porpiglia; Roberto Mario Scarpa; Alchiede Simonato; Carlo Trombetta; Andrea Tubaro; Vincenzo Ficarra Journal: Eur Urol Date: 2020-06-18 Impact factor: 20.096
Authors: Luis López-Fando; Paulina Bueno; David Carracedo; Marcio Averbeck; David M Castro-Díaz; Emmanuel Chartier-Kastler; Francisco Cruz; Roger Dmochowski; Enrico Finazzi-Agrò; Sakineh Hajebrahimi; John Heesakkers; George Kasyan; Tufan Tarcan; Benoit Peyronnet; Mauricio Plata; Bárbara Padilla-Fernández; Frank Van Der Aa; Salvador Arlandis; Hashim Hashim Journal: Eur Urol Focus Date: 2020-06-12
Authors: João A Pereira-Correia; Carlos M P P Gomes; Paulo H N Barbosa; Bruno A Salomão; Heitor S Morais; Valter J F Muller Journal: Neurourol Urodyn Date: 2022-04-02 Impact factor: 2.367